<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Treatment strategies in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> are still limited </plain></SENT>
<SENT sid="1" pm="."><plain>Considering numerous translation failures, research is tending to a preferred use of human-like animal models, and a more-complex perspective of tissue salvaging involving endothelial, glial and neuronal components according to the neurovascular unit (NVU) concept </plain></SENT>
<SENT sid="2" pm="."><plain>During <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) alterations lead to <z:hpo ids='HP_0002181'>brain edema</z:hpo> and hemorrhagic transformation affecting NVU components </plain></SENT>
<SENT sid="3" pm="."><plain>The present study aims on a novel quantification method of <z:chebi fb="2" ids="33602">BBB</z:chebi> damage and affected tissue following experimental <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, closely to the human condition </plain></SENT>
<SENT sid="4" pm="."><plain>Wistar rats underwent embolic middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>, followed by an intravenous application of <z:chebi fb="0" ids="37926">fluorescein isothiocyanate</z:chebi> (<z:chebi fb="0" ids="37926">FITC</z:chebi>)-tagged albumin (≈70kDa) and/or biotinylated rat IgG (≈150kDa) as <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability markers </plain></SENT>
<SENT sid="5" pm="."><plain>Both fluorescent agents revealed similar leakage and allow quantification of <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability by fluorescence microscopy, and after immunohistochemical conversion into a permanent diaminobenzidine label at light-microscopical level </plain></SENT>
<SENT sid="6" pm="."><plain>The following markers were identified for sufficient detection of NVU components: Rat endothelial cell antigen-1 (RECA) and laminin for vessels, Lycopersicon esculentum and Griffonia simplicifolia agglutinin for vessels and microglial subpopulations, ionized calcium binding adaptor molecule 1 (Iba1), CD68 and CD11b for macrophages, activated microglia, monocytes and neutrophils, S100β for astroglia, as well as NeuN and HuC/D for neurons </plain></SENT>
<SENT sid="7" pm="."><plain>This is the first report confirming the usefulness of simultaneously applied <z:chebi fb="0" ids="37926">FITC</z:chebi>-albumin and biotinylated rat IgG as <z:chebi fb="2" ids="33602">BBB</z:chebi> permeability markers in experimental <z:hpo ids='HP_0001297'>stroke</z:hpo>, and, specifying antibodies and lectins for multiple fluorescence labeling of NVU components </plain></SENT>
<SENT sid="8" pm="."><plain>Newly elaborated protocols might facilitate a more-complex outcome measurement in drug development for <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>